198 related articles for article (PubMed ID: 14970862)
1. Demethylation of MAGE promoters during gastric cancer progression.
Honda T; Tamura G; Waki T; Kawata S; Terashima M; Nishizuka S; Motoyama T
Br J Cancer; 2004 Feb; 90(4):838-43. PubMed ID: 14970862
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
Kim KH; Choi JS; Kim IJ; Ku JL; Park JG
World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017
[TBL] [Abstract][Full Text] [Related]
3. Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen.
Futawatari N; Fukuyama T; Yamamura R; Shida A; Takahashi Y; Nishi Y; Ichiki Y; Kobayashi N; Yamazaki H; Watanabe M
World J Gastroenterol; 2017 Dec; 23(46):8200-8206. PubMed ID: 29290656
[TBL] [Abstract][Full Text] [Related]
4. Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
Xie C; Subhash VV; Datta A; Liem N; Tan SH; Yeo MS; Tan WL; Koh V; Yan FL; Wong FY; Wong WK; So J; Tan IB; Padmanabhan N; Yap CT; Tan P; Goh LK; Yong WP
Cell Oncol (Dordr); 2016 Apr; 39(2):175-86. PubMed ID: 26868260
[TBL] [Abstract][Full Text] [Related]
5. Expression of family A melanoma antigen in human gastric carcinoma.
Jung EJ; Kim MA; Lee HS; Yang HK; Lee YM; Lee BL; Kim WH
Anticancer Res; 2005; 25(3B):2105-11. PubMed ID: 16158951
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of methylation of MAGE-A1 and-A3 promoters and expression of DNA methyltransferase in patients with laryngeal squamous cell carcinoma.
Liu S; Zhao Y; Xu Y; Sang M; Zhao R; Gu L; Shan B
Am J Otolaryngol; 2020; 41(1):102318. PubMed ID: 31732299
[TBL] [Abstract][Full Text] [Related]
7. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L
Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
Suzuki T; Yoshida K; Wada Y; Hamai Y; Sentani K; Oue N; Yasui W
Oncol Rep; 2007 Aug; 18(2):329-36. PubMed ID: 17611652
[TBL] [Abstract][Full Text] [Related]
10. Expression of MAGE-A1 mRNA is associated with gene hypomethylation in hepatocarcinoma cell lines.
Xiao J; Chen HS; Fei R; Cong X; Wang LP; Wang Y; Jiang D; Wei L; Wang Y
J Gastroenterol; 2005 Jul; 40(7):716-21. PubMed ID: 16082588
[TBL] [Abstract][Full Text] [Related]
11. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M
Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288
[TBL] [Abstract][Full Text] [Related]
12. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
Qiu G; Fang J; He Y
Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880
[TBL] [Abstract][Full Text] [Related]
13. MAGE expressions mediated by demethylation of MAGE promoters induce progression of non-small cell lung cancer.
Yanagawa N; Tamura G; Oizumi H; Endoh M; Motoyama T
Anticancer Res; 2011 Jan; 31(1):171-5. PubMed ID: 21273595
[TBL] [Abstract][Full Text] [Related]
14. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.
Wischnewski F; Pantel K; Schwarzenbach H
Mol Cancer Res; 2006 May; 4(5):339-49. PubMed ID: 16687489
[TBL] [Abstract][Full Text] [Related]
15. MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases.
Shin KC; Lee KH; Lee CH; Shin IH; Suh HS; Jeon CH
Oncol Rep; 2012 Apr; 27(4):911-6. PubMed ID: 22134685
[TBL] [Abstract][Full Text] [Related]
16. Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines.
Yanagawa N; Tamura G; Honda T; Endoh M; Nishizuka S; Motoyama T
Clin Cancer Res; 2004 Apr; 10(7):2447-51. PubMed ID: 15073123
[TBL] [Abstract][Full Text] [Related]
17. Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells.
Loriot A; De Plaen E; Boon T; De Smet C
J Biol Chem; 2006 Apr; 281(15):10118-26. PubMed ID: 16497664
[TBL] [Abstract][Full Text] [Related]
18. The MAGE-A1 gene expression is not determined solely by methylation status of the promoter region in hematological malignancies.
Suyama T; Ohashi H; Nagai H; Hatano S; Asano H; Murate T; Saito H; Kinoshita T
Leuk Res; 2002 Dec; 26(12):1113-8. PubMed ID: 12443884
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.
De Smet C; Lurquin C; Lethé B; Martelange V; Boon T
Mol Cell Biol; 1999 Nov; 19(11):7327-35. PubMed ID: 10523621
[TBL] [Abstract][Full Text] [Related]
20. Transcription of the MAGE-1 gene and the methylation status of its Ets binding promoter elements: a quantitative analysis in melanoma cell lines using a real-time polymerase chain reaction technique.
Janssen BL; van de Locht LT; Fourkour A; de Smet C; Mensink EJ; van Muijen GN; de Vries TJ
Melanoma Res; 1999 Jun; 9(3):213-22. PubMed ID: 10465576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
